DOI QR코드

DOI QR Code

Long Term Outcomes after Pediatric Liver Transplantation

  • Yazigi, Nada A. (MedStar Georgetown Transplant Institute, Georgetown University Hospital)
  • Received : 2013.12.01
  • Accepted : 2013.12.03
  • Published : 2013.12.30

Abstract

Long term outcomes after liver transplantation are major determinants of quality of life and of the value of this heroic treatment. As short term outcomes are excellent, our community is turning to take a harder look at long term outcomes. The purpose of this paper is to review these outcomes, and highlight proposed treatments, as well as pressing topics needing to be studied. A systemic review of the English literature was carried in PubMed, covering all papers addressing long term outcomes in pediatric liver transplant from 2000-2013. Late outcomes after pediatric liver transplant affect the liver graft in the form of chronic liver dysfunction. The causes include rejection particularly humoral rejection, but also de novo autoimmune hepatitis, and recurrent disease. The metabolic syndrome is a major factor in long term cardiovascular complication risk. Secondary infections, kidney dysfunction and malignancy remain a reality of those patients. There is growing evidence of late cognitive and executive function delays affecting daily life productivity as well as likely adherence. Finally, despite a good health status, quality of life measures are comparable to those of children with chronic diseases. Long term outcomes are the new frontier in pediatric liver transplantation. Much is needed to improve graft survival, but also to avoid systemic morbidities from long term immunosuppression. Quality of life is a new inclusive measure that will require interventions and innovative approaches respectful not only on the patients but also of their social circle.

Keywords

References

  1. Ng VL, Alonso EM, Bucuvalas JC, Cohen G, Limbers CA, Varni JW, et al; Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: report of the studies of pediatric liver transplantation experience. J Pediatr 2012;160:820-6. https://doi.org/10.1016/j.jpeds.2011.10.038
  2. Kelly DA, Bucuvalas JC, Alonso EM, Karpen SJ, Allen U, Green M, et al. Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013;19:798-825. https://doi.org/10.1002/lt.23697
  3. Bekker J, Ploem S, de Jong KP. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant 2009;9:746-57. https://doi.org/10.1111/j.1600-6143.2008.02541.x
  4. Jensen MK, Campbell KM, Alonso MH, Nathan JD, Ryckman FC, Tiao GM. Management and long-term consequences of portal vein thrombosis after liver transplantation in children. Liver Transpl 2013;19: 315-21. https://doi.org/10.1002/lt.23583
  5. Mazariegos GV. Withdrawal of immunosuppression in liver transplantation: lessons learned from PTLD. Pediatr Transplant 2004;8:210-3. https://doi.org/10.1111/j.1399-3046.2004.00173.x
  6. Kaneku H, O'Leary JG, Banuelos N, Jennings LW, Susskind BM, Klintmalm GB, et al. De novo donorspecific HLA antibodies decrease patient and graft survival in liver transplant recipients. Am J Transplant 2013;13:1541-8. https://doi.org/10.1111/ajt.12212
  7. Evans HM, Kelly DA, McKiernan PJ, Hübscher S. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006;43:1109-17. https://doi.org/10.1002/hep.21152
  8. Ekong UD, Melin-Aldana H, Seshadri R, Lokar J, Harris D, Whitington PF, et al. Graft histology characteristics in long-term survivors of pediatric liver transplantation. Liver Transpl 2008;14:1582-7. https://doi.org/10.1002/lt.21549
  9. Scheenstra R, Peeters PM, Verkade HJ, Gouw AS. Graft fibrosis after pediatric liver transplantation: ten years of follow-up. Hepatology 2009;49:880-6. https://doi.org/10.1002/hep.22686
  10. Liberal R, Zen Y, Mieli-Vergani G, Vergani D. Liver transplantation and autoimmune liver diseases. Liver Transpl 2013;19:1065-77.
  11. Desai M, Neuberger J. Chronic liver allograft dysfunction. Transplant Proc 2009;41:773-6. https://doi.org/10.1016/j.transproceed.2009.01.038
  12. Martin SR, Alvarez F, Anand R, Song C, Yin W; SPLIT Research Group. Outcomes in children who underwent transplantation for autoimmune hepatitis. Liver Transpl 2011;17:393-401. https://doi.org/10.1002/lt.22244
  13. Aguilera I, Sousa JM, Gavilan F, Gomez L, Alvarez- Márquez A, Núñez-Roldán A. Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis. Liver Transpl 2011;17:779-88. https://doi.org/10.1002/lt.22302
  14. Gibelli NE, Tannuri U, Pinho-Apezzato ML, Tannuri AC, Maksoud-Filho JG, Andrade WC, et al. Sirolimus in pediatric liver transplantation: a single-center experience. Transplant Proc 2009;41:901-3. https://doi.org/10.1016/j.transproceed.2009.01.054
  15. Sutedja DS, Gow PJ, Hubscher SG, Elias E. Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy. Transplant Proc 2004;36:2334-7. https://doi.org/10.1016/j.transproceed.2004.07.003
  16. Campbell K, Ng V, Martin S, Magee J, Goebel J, Anand R, et al; SPLIT Renal Function Working Group. Glomerular filtration rate following pediatric liver transplantation--the SPLIT experience. Am J Transplant 2010;10:2673-82. https://doi.org/10.1111/j.1600-6143.2010.03316.x
  17. Nobili V, de Ville de Goyet J. Pediatric post-transplant metabolic syndrome: new clouds on the horizon. Pediatr Transplant 2013;17:216-23. https://doi.org/10.1111/petr.12065
  18. Ng VL, Fecteau A, Shepherd R, Magee J, Bucuvalas J, Alonso E, et al; Studies of Pediatric Liver Transplantation Research Group. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a north american multicenter registry. Pediatrics 2008;122:e1128-35. https://doi.org/10.1542/peds.2008-1363
  19. Madhwal S, Atreja A, Albeldawi M, Lopez R, Post A, Costa MA. Is liver transplantation a risk factor for cardiovascular disease? A meta-analysis of observational studies. Liver Transpl 2012;18:1140-6. https://doi.org/10.1002/lt.23508
  20. Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for persons aged 0 through 18 years - United States, 2013. MMWR Surveill Summ 2013;62(Suppl 1):1.
  21. Codoner-Franch P, Bernard O, Alvarez F. Long-term follow-up of growth in height after successful liver transplantation. J Pediatr 1994;124:368-73. https://doi.org/10.1016/S0022-3476(94)70357-4
  22. Sebagh M, Samuel D, Antonini TM, Coilly A, Degli Esposti D, Roche B, et al. Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients. J Hepatol 2012;56:840-7. https://doi.org/10.1016/j.jhep.2011.11.016
  23. Heffron TG, Pillen T, Smallwood G, Rodriguez J, Sekar S, Henry S, et al. Pediatric liver transplantation for acute liver failure at a single center: a 10-yr experience. Pediatr Transplant 2010;14:228-32. https://doi.org/10.1111/j.1399-3046.2009.01202.x
  24. Lao OB, Dick AA, Healey PJ, Perkins JD, Reyes JD. Identifying the futile pediatric liver re-transplant in the PELD era. Pediatr Transplant 2010;14:1019-29. https://doi.org/10.1111/j.1399-3046.2010.01400.x
  25. Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA 2012;307:283-93.
  26. Bohne F, Martínez-Llordella M, Lozano JJ, Miquel R, Benítez C, Londoño MC, et al. Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest 2012;122:368-82. https://doi.org/10.1172/JCI59411
  27. Tryphonopoulos P, Ruiz P, Weppler D, Nishida S, Levi DM, Moon J, et al. Long-term follow-up of 23 operational tolerant liver transplant recipients. Transplantation 2010;90:1556-61. https://doi.org/10.1097/TP.0b013e3182003db7
  28. Abdelmalek MF, Humar A, Stickel F, Andreone P, Pascher A, Barroso E, et al; Sirolimus Liver Conversion Trial Study Group. Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. Am J Transplant 2012;12:694-705. https://doi.org/10.1111/j.1600-6143.2011.03919.x
  29. Berquist RK, Berquist WE, Esquivel CO, Cox KL, Wayman KI, Litt IF. Adolescent non-adherence: prevalence and consequences in liver transplant recipients. Pediatr Transplant 2006;10:304-10. https://doi.org/10.1111/j.1399-3046.2005.00451.x
  30. Shemesh E, Lurie S, Stuber ML, Emre S, Patel Y, Vohra P, et al. A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics 2000;105:E29. https://doi.org/10.1542/peds.105.2.e29
  31. Shemesh E, Annunziato RA, Arnon R, Miloh T, Kerkar N. Adherence to medical recommendations and transition to adult services in pediatric transplant recipients. Curr Opin Organ Transplant 2010;15:288-92. https://doi.org/10.1097/MOT.0b013e32833984a5
  32. Pollock-Barziv SM, Finkelstein Y, Manlhiot C, Dipchand AI, Hebert D, Ng VL, et al. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children. Pediatr Transplant 2010;14:968-75. https://doi.org/10.1111/j.1399-3046.2010.01409.x
  33. Fredericks EM, Dore-Stites D, Well A, Magee JC, Freed GL, Shieck V, et al. Assessment of transition readiness skills and adherence in pediatric liver transplant recipients. Pediatr Transplant 2010;14:944-53. https://doi.org/10.1111/j.1399-3046.2010.01349.x
  34. Huda A, Newcomer R, Harrington C, Blegen MG, Keeffe EB. High rate of unemployment after liver transplantation: analysis of the United Network for Organ Sharing database. Liver Transpl 2012;18:89-99. https://doi.org/10.1002/lt.22408
  35. Burra P, Germani G, Gnoato F, Lazzaro S, Russo FP, Cillo U, et al. Adherence in liver transplant recipients. Liver Transpl 2011;17:760-70. https://doi.org/10.1002/lt.22294
  36. Limbers CA, Neighbors K, Martz K, Bucuvalas JC, Webb T, Varni JW, et al; Studies of Pediatric Liver Transplantation Functional Outcomes Group. Healthrelated quality of life in pediatric liver transplant recipients compared with other chronic disease groups. Pediatr Transplant 2011;15:245-53. https://doi.org/10.1111/j.1399-3046.2010.01453.x
  37. Mohammad S, Hormaza L, Neighbors K, Boone P, Tierney M, Azzam RK, et al. Health status in young adults two decades after pediatric liver transplantation. Am J Transplant 2012;12:1486-95. https://doi.org/10.1111/j.1600-6143.2012.04080.x
  38. Sorensen LG, Neighbors K, Martz K, Zelko F, Bucuvalas JC, Alonso EM; Studies of Pediatric Liver Transplantation (SPLIT) and Functional Outcomes Group (FOG). Cognitive and academic outcomes after pediatric liver transplantation: Functional Outcomes Group (FOG) results. Am J Transplant 2011;11:303-11. https://doi.org/10.1111/j.1600-6143.2010.03363.x

Cited by

  1. Vulnerability and Chronic Illness Management in Pediatric Kidney and Liver Transplant Recipients vol.25, pp.2, 2013, https://doi.org/10.7182/pit2015551
  2. Current developments in pediatric liver transplantation vol.7, pp.11, 2013, https://doi.org/10.4254/wjh.v7.i11.1509
  3. Pediatric liver transplantation: predictors of survival and resource utilization vol.32, pp.5, 2013, https://doi.org/10.1007/s00383-016-3881-6
  4. KidsETransplant : unserious gamepour les enfants malades ou greffés du foie vol.32, pp.12, 2016, https://doi.org/10.1051/medsci/20163212016
  5. An Assessment of Publication Status of Pediatric Liver Transplantation Studies vol.11, pp.12, 2013, https://doi.org/10.1371/journal.pone.0168251
  6. The intensive care medicine clinical research agenda in paediatrics vol.43, pp.9, 2013, https://doi.org/10.1007/s00134-017-4729-9
  7. The value of percutaneous transhepatic treatment of biliary strictures following pediatric liver transplantation vol.50, pp.5, 2013, https://doi.org/10.1590/0100-3984.2016.0087
  8. A mechanism based approach to management of children with end-stage liver disease vol.11, pp.12, 2013, https://doi.org/10.1080/17474124.2017.1367662
  9. Post-traumatic stress disorder in living donors after pediatric liver transplantation : A cross-sectional investigation study vol.98, pp.20, 2013, https://doi.org/10.1097/md.0000000000015565
  10. Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics vol.16, pp.6, 2013, https://doi.org/10.1038/s41575-019-0132-z
  11. Biliary reconstruction before clamp removal to avoid portal vein thrombosis in pediatric living‐donor liver transplantation using hyper‐reduced left lateral segment grafts: A novel technic vol.23, pp.6, 2019, https://doi.org/10.1111/petr.13516
  12. Executive Functioning in Pediatric Solid Organ Transplant Recipients: A Meta-analytic Review vol.104, pp.2, 2020, https://doi.org/10.1097/tp.0000000000002954
  13. School and sports participation post‐transplant vol.25, pp.1, 2021, https://doi.org/10.1111/petr.13791
  14. Outcomes following liver transplantation in young infants: Data from the SPLIT registry vol.21, pp.3, 2013, https://doi.org/10.1111/ajt.16236
  15. Perioperative blood transfusion decreases long-term survival in pediatric living donor liver transplantation vol.27, pp.12, 2013, https://doi.org/10.3748/wjg.v27.i12.1161
  16. Quality of life in long term survivors of pediatric intestinal transplantation compared with liver transplantation and home parenteral nutrition: A prospective single‐center pilot study vol.25, pp.3, 2013, https://doi.org/10.1111/petr.13982
  17. Vitamin D Insufficiency Prior to Paediatric Liver Transplantation Is Associated with Early T-Cell Mediated Rejection vol.8, pp.7, 2013, https://doi.org/10.3390/children8070612
  18. Quality of life of transplanted children and their parents: a cross-sectional study vol.16, pp.1, 2013, https://doi.org/10.1186/s13023-021-01987-y
  19. Evaluation of Graft Fibrosis, Inflammation, and Donor-specific Antibodies at Protocol Liver Biopsies in Pediatric Liver Transplant Patients: A Single-center Experience vol.106, pp.1, 2013, https://doi.org/10.1097/tp.0000000000003649